This study investigates our DNA methylation-based PC biomarker panel (ADAMTS1, BNC1, and CACNA1G genes) in differentiating IPMN-advanced neoplasia from IPMN-LGDs. This evidence concerns the gene CACNA1G and pancreatic intraductal papillary-mucinous neoplasm.